0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      We should abandon randomized controlled trials in the intensive care unit.

      Critical Care Medicine

      Bias (Epidemiology), Blood Transfusion, methods, Critical Illness, therapy, Humans, Intensive Care, Intensive Care Units, Patient Selection, Randomized Controlled Trials as Topic, standards, Time Factors, Treatment Outcome

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The randomized controlled trial is seen by many as the summit of evidence-based medicine, yet, in the intensive care unit, randomized controlled trials can be challenging to conduct, and results are often difficult to interpret and apply. Many randomized controlled trials in intensive care patients have not demonstrated beneficial effects of the intervention under investigation often despite good preclinical and even previous randomized controlled trial evidence. There are many reasons for these negative results including problems with timing, end point selection, and heterogeneous populations. In this article, we will discuss the limitations of randomized controlled trials in the intensive care unit population and highlight the importance of considering other study designs in the challenging intensive care unit environment.

          Related collections

          Author and article information

          Journal
          21164394
          10.1097/CCM.0b013e3181f208ac

          Comments

          Comment on this article